EyePoint (EYPT): Assessing Valuation After Earnings Upgrades and Strong Momentum-Driven Share Gains [Yahoo! Finance]
EyePoint, Inc. (EYPT)
Last eyepoint, inc. earnings: 3/5 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
See our latest analysis for EyePoint. That recent pop fits into a much bigger move, with a roughly 38% 1 month share price return and about 135% year to date. The 1 year total shareholder return near 160% signals strong, building momentum around EyePoint's growth story. If EyePoint's run has you thinking about what else is gaining traction in healthcare, this is a good moment to explore healthcare stocks as potential next ideas for your watchlist. With shares already up sharply and analysts still seeing upside to their targets, the real question now is whether EyePoint remains underestimated by the market or if today's price already reflects tomorrow's growth. With EyePoint last closing at $18.85 against a narrative fair value of $36.08, the valuation framework implies a sizable gap in expectations. The analysts have a consensus price target of $34.417 for EyePoint Pharmaceuticals based on their expectations of its future earnings growth, profit margins and other risk facto
Show less
Read more
Impact Snapshot
Event Time:
EYPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EYPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EYPT alerts
High impacting EyePoint, Inc. news events
Weekly update
A roundup of the hottest topics
EYPT
News
- Eyepoint Pharmaceuticals (NASDAQ:EYPT) was upgraded by analysts at TD Cowen to a "strong-buy" rating.MarketBeat
- EyePoint to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- EyePoint to Present at the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)GlobeNewswire
- Eyepoint Pharmaceuticals (NASDAQ:EYPT) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.MarketBeat
EYPT
Earnings
- 11/5/25 - Miss
EYPT
Sec Filings
- 12/23/25 - Form 4
- 12/8/25 - Form SCHEDULE
- 12/8/25 - Form 4
- EYPT's page on the SEC website